Inhibrx Inc INBX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/30/22 EDT
17.95UNCH (UNCH)
Volume
10,414
Close
17.95quote price arrow up+0.46 (+2.63%)
Volume
591,673
52 week range
7.67 - 47.90
Loading...
  • Open17.46
  • Day High18.94
  • Day Low16.80
  • Prev Close17.49
  • 52 Week High47.90
  • 52 Week High Date11/02/21
  • 52 Week Low7.67
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap701.13M
  • Shares Out39.06M
  • 10 Day Average Volume0.77M
  • Dividend-
  • Dividend Yield-
  • Beta2.71
  • YTD % Change-58.9

KEY STATS

  • Open17.46
  • Day High18.94
  • Day Low16.80
  • Prev Close17.49
  • 52 Week High47.90
  • 52 Week High Date11/02/21
  • 52 Week Low7.67
  • 52 Week Low Date06/16/22
  • Market Cap701.13M
  • Shares Out39.06M
  • 10 Day Average Volume0.77M
  • Dividend-
  • Dividend Yield-
  • Beta2.71
  • YTD % Change-58.9

RATIOS/PROFITABILITY

  • EPS (TTM)-2.86
  • P/E (TTM)-6.28
  • Fwd P/E (NTM)-4.27
  • EBITDA (TTM)-100.599M
  • ROE (TTM)-562.25%
  • Revenue (TTM)7.03M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-1,575.94%
  • Debt To Equity (MRQ)-3,449.82%

EVENTS

  • Earnings Date11/07/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Inhibrx Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Inhibrx, Inc. is a clinical-stage biotechnology company focused on developing a pipeline of biologic therapeutic candidates. The Company’s single domain antibody (sdAb) platform provides a small, simple, modular target binding domain that can be combined in to meet the needs of each biological target. Its products pipeline includes: INBRX-101 is a recombinant alpha-1 antitrypsin (AAT) protein that is comprised of two human AAT, molecules covalently linked to the fragment...
Mark Lappe
Chairman of the Board of Director, President, Chief Executive Officer, Co-Founder
Kelly Deck CPA
Chief Financial Officer
Address
11025 N. Torrey Pines Road, Suite 200
La Jolla, CA
92037
United States

Top Peers

SYMBOLLASTCHG%CHG
ALT
Altimmune Inc
12.77+0.15+1.19%
MRSN
Mersana Therapeutics Inc
6.76+0.34+5.30%
GHRS
GH Research PLC
11.62-0.60-4.91%
VRDN
Viridian Therapeutics Inc
20.51+0.57+2.86%
IPSC
Century Therapeutics Inc
9.89-0.12-1.20%